Risk factors for decreased teicoplanin trough concentrations during initial dosing in critically ill patients

Area of Science:

• Pharmacology
• Critical Care Medicine
• Infectious Diseases

Background:

• Teicoplanin is an important antibiotic for treating serious Gram-positive infections.
• Achieving therapeutic teicoplanin trough concentrations is crucial for treatment efficacy.
• Variability in teicoplanin levels is observed in critically ill patients, necessitating investigation into risk factors.

Purpose of the Study:

• To identify risk factors associated with decreased teicoplanin plasma trough concentrations in critically ill patients.
• To analyze predictors of sub-therapeutic teicoplanin levels relative to initial dosing.

Main Methods:

• Retrospective analysis of data from 80 critically ill patients receiving intravenous teicoplanin.
• Logistic regression analysis to identify risk factors for a >30% decrease in teicoplanin trough concentrations 72 hours post-administration.
• Comparison of predicted versus actual trough concentrations between variation and non-variation groups.

Main Results:

• Actual teicoplanin trough concentrations were significantly lower in the variation group (10.3±2.2 μg/ml) compared to the non-variation group (19.9±5.6 μg/ml).
• Low serum albumin (≤ 2.2 mg/dl) was a significant risk factor (OR = 3.003, p = 0.036).
• High SOFA score (≥ 9) was also a significant risk factor (OR = 3.498, p = 0.025).

Conclusions:

• Elevated SOFA scores and low serum albumin levels are significant risk factors for reduced teicoplanin plasma trough concentrations in critically ill patients.
• These factors should be considered when determining teicoplanin dosing strategies in this population.
• Further research may be warranted to refine dosing guidelines based on these identified risk factors.